Navigation Links
Report on 750 New Medicines in Development for Cancer Released in Baton Rouge
Date:4/21/2008

BATON ROUGE, La., April 21 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) delivered a new report today on medicines in the research pipeline. The report found America's pharmaceutical research companies are testing a record 750 new medicines to help treat cancer.

"We released this report in Baton Rouge because of its particular relevance to the health of the population in Louisiana," says PhRMA Senior Vice President Ken Johnson. The report was unveiled at the State Capitol Building. "According to the Centers for Disease Control and Prevention, Louisiana has the highest death rate from cancer in the United States. In fact, recent data from the American Cancer Society tells us that African American men in Louisiana have the highest death rate and shortest survival rate in the country for all cancers combined, which is why we are releasing this report here to coincide with National Cancer Minority Awareness Week."

The medicines in the report are being tested in human clinical trials or are awaiting approval by the U.S. Food and Drug Administration.

"The medicines now in the research pipeline will add to the substantial progress made in the last five years by biopharmaceutical companies in developing new and more effective cancer treatments," notes PhRMA President and CEO Billy Tauzin. "This strong commitment to research is a product of the determination of the men and women working for America's pharmaceutical research companies to develop new medicines that will enable patients to live longer, healthier, and more productive lives. I am one of those patients who was diagnosed with cancer and was given a new treatment that brought me from the brink of death back to life."

Cancer medicines being developed include 113 for lung cancer, the leading cause of cancer death in the United States; 90 for breast cancer, which is expected to strike more than 180,000 American women this year; 65
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Isis Reports Reduction of apoB-100 Levels in a Murine Model Resulting in Up to 92% Reduction of Atherosclerosis
2. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
3. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
4. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
5. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
6. NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
7. Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
8. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
9. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
10. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
11. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Inflammatory Disorders: Therapies That S...p://www.reportlinker.com/p0165600/Inflammatory-Dis...ne-Response.html ,, The human immune system ca...producing an exaggerated response to a foreign sub...
(Date:11/30/2009)... According to Millennium Research ...ology market intelligence, the nearly $1.2 billion...t 5% over 2008 as patients chose to delay or foreg...e market will, however, begin recovery in 2010, an... growth rates of over 15%. MRG,s facial injectable...
(Date:11/30/2009)... 30 Today at the 95th Scientific A...ociety of North America (RSNA), Bayer HealthCare P...e first patient in an international Phase III clin...florbetaben (BAY 94-9172) PET imaging in the detec...re a pathological hallmark of Alzheimer,s disease....
Breaking Medicine Technology:Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3Kaiser Permanente Debuts New Ads Focused on Technology and Innovation 55897 1Kaiser Permanente Debuts New Ads Focused on Technology and Innovation 55897 2Kaiser Permanente Debuts New Ads Focused on Technology and Innovation 55897 3Employers Launch Grassroots Health Reform Coalition 55895 1Employers Launch Grassroots Health Reform Coalition 55895 2Employers Launch Grassroots Health Reform Coalition 55895 3Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology 13776 1Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology 13776 2Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology 13776 3
...,(Nasdaq: ACEL ) today announced it has confirmed...ccurred in the Phase IIIb clinical trial of its le...ts with unresectable,malignant mesothelioma. The n...company learned that total events in the study had...lan for the study, the company must wait,until 316...
...urnal of the American Medical ... widely used to treat type 2,diabetes has been fou...ardial infarction) or stroke when used alone or in...cording to a Cleveland Clinic study. The study pu...e,American Medical Association reports that use of...
Other Medicine Technology:Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 3Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure 2Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure 3
(Date:11/30/2009)... , NEW YORK, Nov. 30 Report...port is available in its catalogue: ,, Key Pla...merging strategies in ingredients, pharma, food an...649/Key-Players-and-Innovative-Start-Ups-in-Nutrac...-food-and-drinks.html ,, Nutraceuticals are bi...
(Date:11/30/2009)..., WASHINGTON, Nov. 30 - Salon Leau...e" on Monday, December 7(th) to raise funds and cr...d terminal diseases. All proceeds from each haircu...n,s Research Hospital. ,, Salon Leau has been ...e salon is owned by LoAnn Lai, widely recognized f...
(Date:11/30/2009)... , NASHVILLE, Tenn., Nov. 30 /PRNewswire/ -...about gifts for the holidays. For a loved one with...mily members and friends oftentimes struggle with ...ving , one of the leading providers of senior livi...s and dementia care , offers these suggestions. ,...
(Date:11/30/2009)..., CHICAGO, Nov. 30 Physicians at...orted today on results of a study demonstrating th...angiography (cCTA) by Rcadia,s COR Analyzer System...tery stenosis in hospital emergency department (ED...tomated system to enhance the use of cCTA has pote...
(Date:11/30/2009)...ONovember 30, 2009A pet owner knows the enormous j...lly in troubled times. Most pets are considered im...mpanions. A growing body of research now documents...opment, elderly care, mental illness, physical imp...the rehabilitation of incarcerated youth and adult...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3Health News:The therapeutic benefits of the human-animal bond 2
... have found that even a two-minute delay in severi...on //reserves and offset anemia for months. I...oor nations. It is a problem particularly in devel... be reversible, even with iron treatments. ...
... has urged the doctors working in various hospital...nti-rabies vaccine, as recommended by World Health...said that by following the intra-dermal route, the...sociation had taken the decision in view of increa...
... nearly 24% of all diseases in adults and 33% of d...O) said // that all this can be prevented by livin...ensively seen in developing countries and could be...tory infections, various forms of accidental injur...
...e afro American women should be first vaccinated a...s recently approved by the FDA //. This was publi...researchers at The Miriam Hospital and Brown Medic...an article in the January edition of the journal p...
...ween life and death, suffering an extremely rare c...res //a double kidney transplant, which will give ...tely have the perfect match, so they will be donat... for your children. But now things are looking ver...
...wealth to consider alloting specific funds for r...y under the jurisdiction of the state governments... conference, he said that , the measure was essent...h the proposal to federal Health Minister Tony Abb...
Other Medicine News:Health News:Infants have better iron reserves if umbilical cord clamping is delayed 2Health News:Infants have better iron reserves if umbilical cord clamping is delayed 3Health News:Afro American Women at a High Risk of HPV and Hence Should Be Vaccinated 2
McPherson Speculum
Storz Twisted Snare Wire
Thorton Fixation Ring 16 mm
McNeil-Goldman Scleral and Blepharostat Ring
Medicine Products: